Trial intelligence / Profile preview

DPP4 inhibitors in Type 1 Diabetes

2012-002407-18Phase 4Completed

Sponsor
University of Dundee
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of saxagliptin in diabetes mellitus type 1 (T1D), sponsored by University of Dundee. Primary endpoint: Magnitude of adrenaline response at blood glucose of 2.5 mmol/L. Started Jul 2012; status: completed.

02

Drugs

saxagliptin
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2012-002407-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002407-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call